Firmus hype, CBA headwinds and Sonic's earnings problem: 3 fundies sound the alarm

Jun Bei Liu calls Firmus "very high risk", while two other fund managers question the growth credentials of CBA and Sonic Healthcare.
Vishal Teckchandani

Livewire Markets

Everybody loves a great compounder. A business that steadily grows earnings, reinvests capital at attractive rates and rewards shareholders with rising dividends and share prices over time.

But what happens when growth slows, the economics deteriorate, or investors get carried away with a compelling story?

In a recent article inspired by Bank of America's 'Global Steady Compounders' list, I asked four Australian fund managers to nominate their favourite ASX businesses capable of delivering consistent long-term growth.

But I also put the opposing question to them:

Which companies could lose their compounder status, never deserved it in the first place, or are unlikely to ever become one?

Their responses made for interesting reading, with Firmus, Commonwealth Bank and Sonic Healthcare all coming under scrutiny. Here's why.

1. Firmus: An AI growth story with enormous execution risk (Jun Bei Liu)

Jun Bei Liu, TenCap
Jun Bei Liu, TenCap
Artificial intelligence has created enormous excitement around data centres, but Liu believes investors need to distinguish between businesses already benefiting from the boom and those promising substantial future growth.

One company she's particularly cautious about is the much-hyped Firmus, whose proposed US$5.5 billion IPO - potentially Australia's second-largest ever – is facing growing uncertainty amid concerns over its lofty valuation, substantial debt and investor demand.

"Firmus is probably one of the most polarising IPOs I have ever seen. The lack of detail they disclose is unprecedented. I think Firmus is a very high-risk proposition – very high profile, but with enormous risk involved," Liu said.

Her biggest concern is execution risk.

"97% of the data centre capacity they've promised hasn't even been built," she says.

"They might deliver cheaper earnings in two years if they build what they promise, but that's speculative."

Liu isn't bearish on data centres themselves. In fact, she prefers established operators such as NextDC (ASX: NXT) and Goodman Group (ASX: GMG), which have proven track records.

But her preferred way to play the boom is through the businesses actually building the infrastructure.

"We much prefer to be in the companies that actually build those data centres – the engineers, the electrical contractors like Southern Cross Electrical (ASX: SXE) and GenusPlus (ASX: GNP)."

2. Commonwealth Bank: The golden age has come to an end (Chris Scarpato)

Chris Scarpato, Alvia Asset Partners
Chris Scarpato, Alvia Asset Partners
Few businesses have benefited more from Australia's economic growth over the past three decades than the major banks.

Falling interest rates, rising household incomes, expanding credit and a seemingly unstoppable housing market created extraordinarily favourable conditions for lenders.

But Scarpato believes investors should be careful about extrapolating that success into the future.

"It's hard to go past the Big Four banks, and Commonwealth Bank of Australia (ASX: CBA) in particular."

He argues that the tailwinds underpinning decades of earnings and free cash flow growth are now reversing.

Elevated inflation, higher interest rates, cost-of-living pressures, proposed tax changes and falling property prices are creating a very different environment for lenders.

With residential mortgages accounting for a substantial proportion of major bank profitability, weaker property transactions and lending volumes could have significant consequences.

"Given residential property lending has become such a considerable driver of Big Four profitability, we believe there are material headwinds ahead which will put pressure on earnings and free cash flow growth over the coming years."

Scarpato isn't necessarily arguing that CBA has become a poor business. Rather, the conditions that made it such a successful compounder may no longer be as favourable.

3. Sonic Healthcare: Revenue doubles, but earnings go nowhere (Romano Sala Tenna)

Romano Sala Tenna, Katana Asset Management
Romano Sala Tenna, Katana Asset Management
For Sala Tenna, Sonic Healthcare (ASX: SHL) is one company widely regarded as a compounder that doesn't deserve the title.

The pathology, laboratory and diagnostic imaging provider has consistently grown its revenue and dividends over the past decade. On the surface, it looks like a terrific wealth-generation machine.

But Sala Tenna argues that Sonic is a classic example of buying revenue and profit growth at the expense of earnings per share (EPS).

"For the financial year ended 30 June 2016, SHL reported revenues of $5,052m. 10 years later the revenue had doubled to $10.87bn (30 June 2026)," Sala Tenna says.

"Yet at the same time EPS has basically flatlined. In the 2016 FY, EPS was $1.09 per share. 10 years later it has barely moved, at just $1.23 per share. In FY25, EPS was $1.09.7cps – almost identical to the level 9 years earlier!"

And what about those growing dividends?

"And the dividend growth? Well that’s been almost entirely attributable to an ever-increasing payout ratio, to the point where it peaked at 100.3% of EPS in FY25."

For investors, it might be time for a health check of Sonic's financials. After all, genuine compounding requires sustained growth in earnings attributable to each share, not simply a bigger business.

........
Livewire gives readers access to information and educational content provided by financial services professionals and companies ("Livewire Contributors"). Livewire does not operate under an Australian financial services licence and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any advice given. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs. Before making a decision please consider these and any relevant Product Disclosure Statement. Livewire has commercial relationships with some Livewire Contributors.

1 topic

2 stocks mentioned

2 contributors mentioned

Vishal Teckchandani
Lead Investment Writer & Presenter
Livewire Markets

I have over 15 years’ experience covering financial markets and property, with a particular interest in ETFs and personal finance. I split my time between Australia and Canada to bring a global perspective to my work.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment